Ingevity Rises More Than 18% in 3 Months: What's Driving the Stock?

15.01.26 14:47 Uhr

Werte in diesem Artikel

Ingevity Corporation’s NGVT shares have gained 18.7% over the past three months. The company has also outperformed the Zacks Chemical - Specialty industry’s 4.8% growth and the S&P 500’s 6.3% increase over the same period.Image Source: Zacks Investment ResearchStrategic Divestiture Taps Shareholder Value for NGVTThe company's portfolio optimization through the sale of its North Charleston crude tall oil (“CTO”) refinery assets and the majority of the Performance Chemicals Industrial Specialties product line to Mainstream Pine Products for $110 million in cash, with the possibility of zero to $19 million in contingent consideration on future business performance milestones, contributed to the share price spike.Through the sale of CTO-based product lines and retaining the Pavement Technologies business and other lignin-based dispersant products, Ingevity is sharpening its focus on higher-margin, specialty applications while improving capital efficiency. Acquisitions Strengthen Growth and Margins for IngevityIngevity’s disciplined acquisition strategy has materially strengthened its portfolio and earnings quality. The acquisition of Georgia-Pacific’s pine chemicals has already paid off through better production efficiency, lower sourcing and logistics costs, and improved margins. Similarly, the Capa caprolactone acquisition brought in a differentiated technology platform with a wide range of applications across coatings, adhesives and specialty polymers, creating a sustainable and higher-quality revenue stream.The Ozark Materials acquisition further expanded Ingevity’s exposure to the construction and infrastructure markets, positioning it to benefit from long-term infrastructure demand. Collectively, these acquisitions underscore Ingevity’s ability to deploy capital into profitable use.Ingevity Corporation Price and Consensus Ingevity Corporation price-consensus-chart | Ingevity Corporation QuoteNGVT’s Zacks Rank & Key PicksNGVT currently has a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Agnico Eagle Mines Limited AEM, Kinross Gold Corporation KGC and Avino Silver & Gold Mines Ltd. ASM.At present, AEM and KGC sport a Zacks Rank #1 (Strong Buy) each, while ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for AEM’s 2025 earnings is pegged at $7.85 per share, indicating a rise of 85.6%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 11.63%. AEM’s shares have gained 133.8% over the past year.The Zacks Consensus Estimate for KGC’s 2025 earnings is pinned at $1.68 per share, indicating a 147.1% year-over-year increase. Its shares have surged 225.4% over the past year.The Zacks Consensus Estimate for ASM’s 2025 fiscal-year earnings is pinned at 17 cents per share, indicating a 13.3% year-over-year increase. ASM’s shares have gained 491.2% over the past year. Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kinross Gold Corporation (KGC): Free Stock Analysis Report Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report Avino Silver (ASM): Free Stock Analysis Report Ingevity Corporation (NGVT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ingevity und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Ingevity

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ingevity

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ingevity Corp When Issued

Wer­bung

Analysen zu Ingevity Corp When Issued

DatumRatingAnalyst
18.07.2019Ingevity OutperformBMO Capital Markets
11.12.2018Ingevity HoldStifel, Nicolaus & Co., Inc.
10.06.2016Ingevity BuyBB&T Capital Markets
DatumRatingAnalyst
18.07.2019Ingevity OutperformBMO Capital Markets
11.12.2018Ingevity HoldStifel, Nicolaus & Co., Inc.
10.06.2016Ingevity BuyBB&T Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ingevity Corp When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen